Gene News and Research

Latest Gene News and Research

New study maps global immune gene diversity across multiple populations

Inherited variations in antibody genes can affect how we respond to infections and vaccines, show two new studies from Karolinska Institutet in Sweden, published in the journal Immunity.

26 Mar 2026

The new microchip electrophoresis system MultiNA II MCE-301- High sensitivity detection, improved analysis function and operability

Shimadzu has recently released the MultiNA II MCE-301 microchip electrophoresis system. By automating the entire process of electrophoresis, which takes more than two hours by hand (creation of gels, dispensing reagents, dispensing sample, separation, dyeing, cleaning of equipment), the company significantly improves the efficiency of genetic analysis operations.

From Shimadzu Europa GmbH 26 Mar 2026

New brain atlas reveals how the human neocortex forms over time

In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and the brain later in life, investigators at Johns Hopkins Medicine and colleagues throughout the world have been mapping the molecular construction of the human brain.

25 Mar 2026

CDC tracks SARS-CoV-2 BA.3.2 global rise and finds early signals in U.S. wastewater

CDC surveillance shows that the highly divergent SARS-CoV-2 variant BA.3.2 spread to at least 23 countries and was detected in U.S. travelers, patients, airplane wastewater, and wastewater samples across multiple states. The report highlights wastewater and traveler-based genomic surveillance as early warning tools while noting that BA.3.2 has immune-evasion potential but has not rapidly displaced other circulating lineages.

25 Mar 2026

Chronic inflammation leaves epigenetic scars that increase future cancer risk

Chronic inflammation can raise a person's risk of cancer, and a new study reveals key details about how that might happen in the gut and points to better ways to identify and reduce risk.

25 Mar 2026

Early blood test could guide personalized lymphoma treatment decisions

Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four chemotherapy drugs.

25 Mar 2026

Blood pressure drug boosts effectiveness of cancer therapy

In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found that the FDA-approved blood pressure drug telmisartan can significantly enhance the cancer-killing activity of the targeted therapy olaparib, potentially expanding its use to many more patients.

25 Mar 2026

Immune cells use neurotransmitters to regulate health and disease

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, 2026, in Immunity & Inflammation, provides a timely and authoritative review of how innate and adaptive immune cells-including macrophages, dendritic cells, natural killer cells, T cells, and B cells-produce and respond to classic neurotransmitters.

25 Mar 2026

New pathway enhances brown fat thermogenesis and metabolic health

Researchers have determined how a key protein activates brown fat by expanding blood vessels and nerves in the heat-generating tissue.

25 Mar 2026

Eating more dairy and calcium may lower metabolic syndrome odds

Research links higher dietary calcium and dairy consumption to reduced odds of metabolic syndrome, highlighting potential dietary interventions for health.

25 Mar 2026

Study identifies rare genetic disorder linked to premature aging and cognition

Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have defined a new genetic disease marked by premature aging and deficits in brain function.

24 Mar 2026

CREB5 drives stem cell-like transcriptional programs in aggressive prostate cancer

A new research paper was published in Volume 17 of Oncotarget on March 17, 2026, titled "CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer."

24 Mar 2026

How behavior and biology combine to drive addiction

Genomic analyses reveal that addiction risk is influenced by both shared behavioral traits and specific biological factors, informing prevention and treatment.

24 Mar 2026

Palmatine improved fatty liver markers in a preclinical type 2 diabetes study

Researchers used a bioinformatics-plus-rat-model approach to investigate how palmatine may help treat T2DM-associated MASLD, identifying five core targets: ADRB2, BCL3, EGR1, FOS, and MAP3K8. In rats, palmatine improved liver injury, inflammation, oxidative stress, glycolipid metabolism, steatosis, and fibrosis, while reducing apoptosis-related signaling, providing a preclinical foundation for further therapeutic study.

23 Mar 2026